MESO
Mesoblast Limited (MESO) Investor Questions
Review Mesoblast Limited (MESO) faq with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Company
- Mesoblast Limited
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 37
- Annual revenue
- $120.79M
- Annual net income
- $-57.76M
- Annual free cash flow
- $-44.73M
Mesoblast Limited (MESO) Investor Questions research
Mesoblast Limited trades under the ticker MESO. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review MESO through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.